BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 22258766)

  • 41. Developing Spindlin1 small-molecule inhibitors by using protein microarrays.
    Bae N; Viviano M; Su X; Lv J; Cheng D; Sagum C; Castellano S; Bai X; Johnson C; Khalil MI; Shen J; Chen K; Li H; Sbardella G; Bedford MT
    Nat Chem Biol; 2017 Jul; 13(7):750-756. PubMed ID: 28504676
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Suppressive role exerted by microRNA-29b-1-5p in triple negative breast cancer through SPIN1 regulation.
    Drago-Ferrante R; Pentimalli F; Carlisi D; De Blasio A; Saliba C; Baldacchino S; Degaetano J; Debono J; Caruana-Dingli G; Grech G; Scerri C; Tesoriere G; Giordano A; Vento R; Di Fiore R
    Oncotarget; 2017 Apr; 8(17):28939-28958. PubMed ID: 28423652
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A tudor domain protein SPINDLIN1 interacts with the mRNA-binding protein SERBP1 and is involved in mouse oocyte meiotic resumption.
    Chew TG; Peaston A; Lim AK; Lorthongpanich C; Knowles BB; Solter D
    PLoS One; 2013; 8(7):e69764. PubMed ID: 23894536
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Histone demethylase KDM5A is regulated by its reader domain through a positive-feedback mechanism.
    Torres IO; Kuchenbecker KM; Nnadi CI; Fletterick RJ; Kelly MJ; Fujimori DG
    Nat Commun; 2015 Feb; 6():6204. PubMed ID: 25686748
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Critical role of histone demethylase RBP2 in human gastric cancer angiogenesis.
    Li L; Wang L; Song P; Geng X; Liang X; Zhou M; Wang Y; Chen C; Jia J; Zeng J
    Mol Cancer; 2014 Apr; 13():81. PubMed ID: 24716659
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Distinct mode of methylated lysine-4 of histone H3 recognition by tandem tudor-like domains of Spindlin1.
    Yang N; Wang W; Wang Y; Wang M; Zhao Q; Rao Z; Zhu B; Xu RM
    Proc Natl Acad Sci U S A; 2012 Oct; 109(44):17954-9. PubMed ID: 23077255
    [TBL] [Abstract][Full Text] [Related]  

  • 47. SPIN1 triggers abnormal lipid metabolism and enhances tumor growth in liver cancer.
    Zhao M; Bu Y; Feng J; Zhang H; Chen Y; Yang G; Liu Z; Yuan H; Yuan Y; Liu L; Yun H; Wang J; Zhang X
    Cancer Lett; 2020 Feb; 470():54-63. PubMed ID: 31790762
    [TBL] [Abstract][Full Text] [Related]  

  • 48. SPIN1 promotes tumorigenesis by blocking the uL18 (universal large ribosomal subunit protein 18)-MDM2-p53 pathway in human cancer.
    Fang Z; Cao B; Liao JM; Deng J; Plummer KD; Liao P; Liu T; Zhang W; Zhang K; Li L; Margolin D; Zeng SX; Xiong J; Lu H
    Elife; 2018 Mar; 7():. PubMed ID: 29547122
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The histone code reader Spin1 controls skeletal muscle development.
    Greschik H; Duteil D; Messaddeq N; Willmann D; Arrigoni L; Sum M; Jung M; Metzger D; Manke T; Günther T; Schüle R
    Cell Death Dis; 2017 Nov; 8(11):e3173. PubMed ID: 29168801
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular basis for histone H3 "K4me3-K9me3/2" methylation pattern readout by Spindlin1.
    Zhao F; Liu Y; Su X; Lee JE; Song Y; Wang D; Ge K; Gao J; Zhang MQ; Li H
    J Biol Chem; 2020 Dec; 295(49):16877-16887. PubMed ID: 32994220
    [TBL] [Abstract][Full Text] [Related]  

  • 51. SPIN1, negatively regulated by miR-148/152, enhances Adriamycin resistance via upregulating drug metabolizing enzymes and transporter in breast cancer.
    Chen X; Wang YW; Gao P
    J Exp Clin Cancer Res; 2018 May; 37(1):100. PubMed ID: 29743122
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Suppression of SPIN1-mediated PI3K-Akt pathway by miR-489 increases chemosensitivity in breast cancer.
    Chen X; Wang YW; Xing AY; Xiang S; Shi DB; Liu L; Li YX; Gao P
    J Pathol; 2016 Aug; 239(4):459-72. PubMed ID: 27171498
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MicroRNA-409: Molecular functions and clinical applications in cancer.
    Rajabloo Y; Latifi H; Akhlaghipour I; Taghehchian N; Moghbeli M
    Biochem Biophys Rep; 2024 Jul; 38():101728. PubMed ID: 38737729
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Discovery of a Potent, Selective, and Cell-Active SPIN1 Inhibitor.
    Xiong Y; Greschik H; Johansson C; Seifert L; Gamble V; Park KS; Fagan V; Li F; Chau I; Vedadi M; Arrowsmith CH; Brennan P; Fedorov O; Jung M; Farnie G; Liu J; Oppermann U; Schüle R; Jin J
    J Med Chem; 2024 Apr; 67(7):5837-5853. PubMed ID: 38533580
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular insights into Spindlin1-HBx interplay and its impact on HBV transcription from cccDNA minichromosome.
    Liu W; Yao Q; Su X; Deng Y; Yang M; Peng B; Zhao F; Du C; Zhang X; Zhu J; Wang D; Li W; Li H
    Nat Commun; 2023 Aug; 14(1):4663. PubMed ID: 37537164
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predictive biomarkers of immunotherapy response with pharmacological applications in solid tumors.
    Kovács SA; Fekete JT; Győrffy B
    Acta Pharmacol Sin; 2023 Sep; 44(9):1879-1889. PubMed ID: 37055532
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Loss-of-function variant in SPIN4 causes an X-linked overgrowth syndrome.
    Lui JC; Wagner J; Zhou E; Dong L; Barnes KM; Jee YH; Baron J
    JCI Insight; 2023 May; 8(9):. PubMed ID: 36927955
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dysbiotic human oral microbiota alters systemic metabolism via modulation of gut microbiota in germ-free mice.
    Yamazaki K; Miyauchi E; Kato T; Sato K; Suda W; Tsuzuno T; Yamada-Hara M; Sasaki N; Ohno H; Yamazaki K
    J Oral Microbiol; 2022; 14(1):2110194. PubMed ID: 35966937
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    Tong W; Yang L; Liu L; Liu X; Luo N
    Onco Targets Ther; 2022; 15():555-570. PubMed ID: 35611367
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recognition of Dimethylarginine Analogues by Tandem Tudor Domain Protein Spindlin1.
    Porzberg MRB; Moesgaard L; Johansson C; Oppermann U; Kongsted J; Mecinović J
    Molecules; 2022 Feb; 27(3):. PubMed ID: 35164245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.